I have read a bit about squalamine and it SOUNDS terrific as it is an eye drop instead of an injection. However, if it had truly great potential - then there would be a lot of institutional investors here. Adam Feurenstein does not believe S is prove to be successful. It failed to work before.
Be careful here folks - this is a "make it or break it" type investment. Is the risk really worth it?